Matthew Hobson
InvestorAnalyst at Catalio Capital Management, LP
Baltimore, Maryland
Writes $100K β $5M checks Β· typically $1.5M
About
Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.
Invests in
BiotechDigital Health
Experience
- Catalio Capital ManagementPrincipalcurrent2023 β presentNew York, United States
- Catalio Capital ManagementSr. Analyst2020 β 2023New York, New York, United States
- The Johns Hopkins University School of MedicinePostdoctoral Researcher2020 β 2021Baltimore, Maryland, United States
- The Johns Hopkins University School of MedicinePHD Candidate2013 β 2020Baltimore, Maryland
- Emory University Department of ChemistryUndergraduate Researcher2010 β 2013
- National Institutes of HealthContractor2010 β 2012NIH Clinical Center, Bethesda, MD
- Walter Reed Army Institute of ResearchIntern2009
Education
- The Johns Hopkins University School of MedicineDoctor of Philosophy - PhD, Biophysics and Biophysical Chemistry2013 β 2019
- Emory UniversityBachelor of Science (B.S.), Chemistry and Physics2009 β 2013
- The Johns Hopkins UniversityDoctor of Philosophy (PhD), Biophysics
Skills & more
Financial AnalysisValuationRegulatory AnalysisClinical Trial AnalysisProtein EngineeringStructural BiologyMarket AnalysisData AnalysisMicroscopyAssay DevelopmentMarket ResearchProtein Expression
+12 more
Fluorescence MicroscopyProtein PurificationCryoEMBiophysicsComputational BiologyX-ray crystallographyVector CloningChemical SynthesisFluorescence AnisotropyProtein CrystallizationNanoparticle FunctionalizationMagnetic TweezersFrom Matthew's professional profile.
Same school
Also attended The Johns Hopkins University School of Medicine23
Hal PazInvestor at Khosla VenturesBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesSamantha GuinnAnalyst at Novartis Venture FundGreg HornerInvestor at Sand Hill Angels
+ 17 more
Also attended Emory University105
Dave MunichielloInvestor at GV (Google Ventures)Ryan HaysBoard Member at CincyTechJustin RobenyAssociate at Osage University PartnersZitong SuAssociate at Marlin Equity PartnersGurbani SinghPrincipal - Investor Relations at Marlin Equity PartnersCole LundquistPrincipal at QED Investors
+ 99 more
Also attended The Johns Hopkins University206
Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesCaitlinChief of Staff at Hummingbird VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General Catalyst
+ 200 more
Shared employers
Also worked at Catalio Capital Management10
George C. PetrocheilosCo-Founder and Managing Partner at Catalio Capital Management, LPR. Jacob VogelsteinCo-Founder and Managing Partner at Catalio Capital Management, LPNicholas von GuionneauSenior Analyst at Catalio Capital Management, LPJohn Henry IuckerGeneral Partner and Head of Credit at Catalio Capital Management, LPVicky SostilioVice President at Catalio Capital Management, LPIsaac RoPartner at Catalio Capital Management, LP
+ 4 more
Also worked at The Johns Hopkins University School of Medicine9
Yoola AdenijiSenior Associate at LRVHealthRobert LordVenture Partner at LionBirdLuc StarmansPartner at Brightlands Venture PartnersMichelle LevinePrincipal at Solasta VenturesDoug KerrScience Advisor at Exceptional VenturesKiran YemulFellow, Healthcare & Life Sciences at Braven
+ 3 more
Also worked at National Institutes of Health47
Jun JeonInvestor at Khosla VenturesUri LopatinInvestor at Khosla VenturesMax ColbertPhysician-Entrepreneur at Medical Excellence CapitalIan ChiangPartner at Flare Capital PartnersGrant VerstandigFounder, Chairman, & CEO at Red Cell IncubationLeela SrinivasanCEO, Parity at Bull City Venture Partners
+ 41 more
Investments
Board seats
Iambic TherapeuticsLassen TherapeuticsOctant TherapeuticsPink Dx
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Adam Riess
Venture Partner at Catalio Capital Management, LP
Alan Ashworth
Venture Partner at Catalio Capital Management, LP
Christine E. 'Kricket' Seidman
Venture Partner at Catalio Capital Management, LP
Dan Littman
Venture Partner at Catalio Capital Management, LP
David Sinclair
Venture Partner at Catalio Capital Management, LP
Diamantis Xylas
Analyst at Catalio Capital Management, LP
Frances H. Arnold
Venture Partner at Catalio Capital Management, LP
Freda Lewis-Hall
Venture Partner at Catalio Capital Management, LP



.png)






































